L
LyGenesis
0 followers
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end-stage liver disease.
Org chart
Collapse
Paulo A Fontes
Co-founder & Medical Advisor
Eric Lagasse
CSO
Jacqueline Jeha, MPH
Director of Clinical Operations and Corporate Development
Paulo Fontes, MD, FACS
Co-founder & Medical Advisor